The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis

Pathology and Oncology Research

Volumn 7, Issue 1, 2001, Pages 14-23

  John, Anitha ^a   Tuszynski, George ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Gelatinases; Matrix metalloproteinases; Metalloproteinase inhibitors; Metastasis; Tumor angiogenesis

Indexed keywords

4 DEDIMETHYLAMINOSANCYCLINE; AE 941; BATIMASTAT; CAPTOPRIL; GELATINASE; GELATINASE A; GELATINASE B; MARIMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PRINOMASTAT; REBIMASTAT; RECOMBINANT ENZYME; TETRACYCLINE; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR MARKER;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; CANCER INVASION; CLINICAL TRIAL; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; GENE CONTROL; HUMAN; METASTASIS; MYALGIA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FAMILY; REVIEW; TUMOR GROWTH; TUMOR VASCULARIZATION;

EID: 0034956272     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03032599     Document Type: Review

References (75)

1. Patterns of metastasis in human malignancies
2. Principles of molecular cell biology of cancer: Cancer Metastasis
3. Mechanism of mineral solubilisation and matrix degradation in osteoclastic bone resorption
4. Coordinated expression of ECM-degrading proteinases and their inhibitors regulates mammary epithelial function during involution
5. Matrix metalloproteinase 9 level predicts optimal collagen deposition during early wound repair in humans
6. Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: A potentially useful laboratory marker
7. Matrix Metalloproteinases
8. Proteinases and myocardial extracellular matrix turnover
9. Collagenolytic activity in amphibian tissues: A tissue culture assay
10. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and *-length fragments
11. Metalloproteinases and their inhibitors in matrix remodeling
12. Proteases and their inhibitors in human brain tumours: A review
13. Matrix metalloproteinases and coronary artery disease: A novel therapeutic target
14. Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells
15. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines
16. Effects of epidermal growth factor on the invasion activity of the bladder cancer cell line
17. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro
18. Liver metastasis formation by laminin-1 peptide (LQVQLSIR)-adhesion selected B16-F10 melanoma cells
19. Induction of tissue inhibitor and matrix metalloproteinase by serum in human heart-derived fibroblast and endomyocardial endothelial cells
20. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells
21. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells
22. Expression of thrombospondin-1 in cancer: A role in tumor progression
23. Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells
24. Activation of type IV pro-collagenases by human tumor-associated trypsin-2
25. Differential regulation of extracellular matrix metalloproteinase and tissue inhibitor by heparin and cholesterol in fibroblast cells
26. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants
27. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblast: Purification and activation of the precursor and enzymatic properties
28. Membrane-type matrix metalloproteinases (MT-MMPs) in tumor metastasis
29. Inhibitors of metalloproteinases
30. Tissue Inhibitors of metalloproteinases: Structure, regulation and biological functions
31. Tissue inhibitor of metalloproteinases (TIMP-1) RNA is expresses at elevated levels in malignant non-Hodgkin's lymphomas
32. Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP-3)
33. Angiogenesis in cancer, vascular, rheumatoid and other disease
34. Tumor angiogenesis: Therapeutic implications
35. Tumour angiogenesis
36. Tumor-associated angiogenesis: Mechanisms, clinical implications, and therapeutic strategies
37. Changing views of the role of matrix metalloproteinases in metastasis
38. The regulation of neovascularization by matrix metalloproteinases and their inhibitors
39. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells - Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation
40. Matrix metalloproteinases in blood vessel development in human fetal skin and in cutaneous tumors
41. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases
42. Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP)
43. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9
44. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
45. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis if hypertropic chondrocytes
46. Selection of invasive and metastatic subpopulation from a human lung adenocarcinoma cell line
47. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: Suppression by somatic cell hybridization with early stage melanoma cells
48. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion
49. Proteolytic activity of human non-Hodgkin's lymphomas
50. Metastatic ability of MXT mouse mammary subpopulations coorelates with clonal expression and/or membrane-association of gelatinase A
51. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma
52. Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2
53. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation bur reduces tumor growth
54. Matrix metalloproteinase gene expression
55. Distinct pattern of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 mRNA expression in human colorectal cancer and liver metastases
56. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in thyroid C-cells and medullary thyroid carcinomas
57. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: Possible implications for the role of desmoplastic fibroblasts
58. Membrane-type matrix metalloproteinase-1 (MT1-MMP) gene is overexpressed in highly invasive hepatocellular carcinomas
59. Density-dependent regulation of cell-surface association of matrix metalloproteinase-2 (MMP-2) in breast-carcinoma cells
60. Elevated levels of serum and plasma metalloproteinases in patients with gastric cancer
61. Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension
62. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer
63. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases
64. Inhibition of invasion and metastasis in cell transfected with an inhibitor of metalloproteinases
65. Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo
66. Transfection of an invasive human astrocytoma cell line with a TIMP-1 cDNA: Modulation of astrocytoma invasive potential
67. Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type-IV collagenase
68. Matrix metalloproteinase-9 in tumor cell invasion
69. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor
70. Matrix Metalloproteinase inhibition prevents peritoneal carcinomatosis development and prolongs survival in rats
71. Marimastat (BB2516): Current status of development
72. Marimastat in patients with advanced pancreatic cancer: A dose finding study
73. Experimental drugs and drug combinations in pancreatic cancer